Oesophageal bandaging: A new opportunity for thermosetting polymers

S.T.P. Pharma Sciences

Volumn 10, Issue 4, 2000, Pages 293-301

  Potts, A M ^a   Wilson, C G ^a   Stevens, H N E ^a   Dobrozsi, D J ^a   Washington, N ^a   Frier, M ^a   Perkins, A C ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Bioadhesion; Gastro oesophageal reflux disease; Oesophageal; Pluronic; Thermosetting polymers

Indexed keywords

POLOXAMER; SUCRALFATE;

BANDAGE; DRUG DELIVERY SYSTEM; ESOPHAGUS DISEASE; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; HUMAN; REVIEW; TREATMENT INDICATION; UNITED KINGDOM;

EID: 0033838673     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Effect on experimental esophageal injury
2. Review article: Oesophageal mucosal resistance
3. Therapy of esophagitis
4. Anatomy, physiology and pharmacology of the upper gastrointestinal tract
5. Dysfunction of the esophagogastric junction
6. Esophageal disorders in the elderly
7. Special diagnostic and therapeutic considerations in elderly patients with upper gastrointestinal disease
8. Esophagitis in scleroderma, prevalence and risk factors
9. Pill-induced esophageal strictures: Clinical features and risk factors for development
10. Esophageal obstruction after ingestion of a fiber-containing diet pill
11. Drug-induced esophageal strictures
12. Oesophageal obstruction and ulceration caused by oral potassium therapy
13. Pill-induced esophagitis caused by oral rifampin
14. Pillesophagitis
15. Drug-induced esophagitis
16. Pill-induced esophageal injury: Case reports and review of the medical literature
17. Esophagitis associated with the use of alendronate
18. Development of a method for study of the tendency of drug products to adhere to the esophagus
19. Adherence of various oral dosage forms to the esophagus
20. The effect of formulation on oesophageal transit
21. Impaired oesophageal transit of capsule versus tablet formulations in the elderly
22. Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulations
23. Esophageal transit, disintegration and gastric emptying of a risedronate placebo tablet in GERD and matched normal control subjects
24. Effect of bolus composition on esophageal transit: Concise communication
25. Oesophageal transit of small tablets
26. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett
27. Distribution of cytokeratin markers in Barrett's specialized columnar epithelium
28. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota
29. Altered lower esophageal sphincter function during early pregnancy
30. Toxic bile acids in gastro-oesophageal reflux disease: Influence of gastric acidity
31. Gastric emptying in patients with gastroesophageal reflux
32. Pathogenesis of reflux esophagitis
33. Effect of time of dosing relative to a meal on the raft formation of an anti-reflux agent
34. Non-invasive detection of gastro-oesophageal reflux using an ambulatory system
35. History of the development of sucralfate
36. Sucralfate - 24 years later: Current concepts of its protective and therapeutic actions
37. Alternatives to antacids
38. Chemistry of sucralfate
39. Binding of sucralfate to the mucosal surface
40. A comparison of the gastric retention of a sucralfate gel and a sucralfate suspension
41. Scintigraphic study of oesophageal transit and retention
42. Buccal and gastrointestinal drug delivery systems
43. Mucoadhesive buccal patches for peptide delivery
44. Bioadhesive dosage forms for buccal/gingival administration
45. Semisolid dosage forms as buccal bioadhesives
46. Mucoadhesive ocular drug delivery systems
47. Ocular bioadhesive delivery systems
48. Ocular drug delivery. Mechanism(s) of corneal drug transport and mucoadhesive delivery systems
49. Bioadhesive dosage forms for nasal administration
50. Nasal drug delivery
51. Bioadhesive dosage forms for vaginal and intrauterine application
52. Binding of acrylic polymers to mucin/epithelial surfaces: Structure-property relationships
53. Radionuclide transit studies in the detection of oesophageal dysmotility
54. Environmentally sensitive polymers and hydrogels. <> biomaterials
55. Temperature-induced gelation Pluronic-g-poly(acrylic acid) graft copolymers for prolonged drug delivery to the eye
56. Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery
57. Graft copolymers that exhibit temperature-induced phase transitions over a wide range of pH
58. The precorneal residence of a thermally sensitive hydrogel
59. Determination of the nasal retention of smart hydrogel using gamma scintigraphy
60. Smart Hydrogel: A novel mucosal delivery system
61. Interpenetrating polymer networks for sustained dermal delivery
62. In vivo determination of the oesophageal retention of sSmart Hydrogel
63. Loss of gelation ability of Pluronic F127 in the presence of some salts
64. Self-assembly in aqueous block copolymer solutions
65. Antacids, structure, physicochemical properties and neutralization capacities